[Therapy of gastric ulcer with carbenoxolon sodium. Results of a double-blind study].
作者信息
Ottenjann R, Rösch W
出版信息
Med Klin. 1970 Jan 9;65(2):74-7.
PMID:4943233
Abstract
摘要
相似文献
1
[Therapy of gastric ulcer with carbenoxolon sodium. Results of a double-blind study].
Med Klin. 1970 Jan 9;65(2):74-7.
2
Controlled double blind trial of carbenoxolone in gastric and duodenal ulcer.
Int J Clin Pharmacol. 1974 Dec;10(4):309-18.
3
Proceedings: A double blind trial of carbenoxolone and geranyl farnesylacetate in gastric ulcer.
Gut. 1974 Oct;15(10):833.
4
[Treatment of gastric and duodenal ulcers using carbenoxolone sodium. (Double blind trial)].
Munch Med Wochenschr. 1972 May 12;114(19):925-9.
5
Carbenoxolone in the treatment of gastric ulcer.
Am J Gastroenterol. 1973 Jul;60(1):23-9.
6
[Carbenoxolon in treatment of stomach ulcer, duodenal ulcer and ulcerative colitis].
Z Allgemeinmed. 1972 Oct 31;48(30):1411-4.
7
Review of carbenoxolone: editorial comment.
Am J Gastroenterol. 1973 Jul;60(1):81-3.
8
[Double-blind study with carbenoxolone-sodium in gastric ulcer].
Med Klin. 1971 Mar 12;66(11):383-5.
9
[Plasma renin activity, aldosterone excretion rate, serum electrolytes and blood pressure before and following treatment with carbenoxolone-sodium].
Verh Dtsch Ges Inn Med. 1971;77:1008-13.
10
Gastric ulcer treatment with carbenoxolone sodium ('biogastrone').
N Z Med J. 1966 May;65(405):308-9.
引用本文的文献
1
Glycyrrhiza glabra HPLC fractions: identification of Aldehydo Isoophiopogonone and Liquirtigenin having activity against multidrug resistant bacteria.
BMC Complement Altern Med. 2018 May 2;18(1):140. doi: 10.1186/s12906-018-2207-8.
2
[Influence of carbenoxolone therapy on the renin-angiotensin-aldosterone system].
Klin Wochenschr. 1971 Dec 1;49(23):1285-9. doi: 10.1007/BF01733084.
3
Clinical course of peptic ulcer and the effect of pharmacotherapy:--multi-institutional double-blind controlled study--.
Gastroenterol Jpn. 1975;10(4):323-41. doi: 10.1007/BF02776363.
4
Carbenoxolone: a review of its pharmacological properties and therapeutic efficacy in peptic ulcer disease.
Drugs. 1976;11(4):245-307. doi: 10.2165/00003495-197611040-00002.
Zotero 插件